Coverart for item
The Resource Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies

Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies

Label
Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary
Title
Breakthrough business models
Title remainder
drug development for rare and neglected diseases and individualized therapies: workshop summary
Statement of responsibility
[edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies
Title variation
Drug development for rare and neglected diseases and individualized therapies
Contributor
Subject
Language
eng
Summary
"The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development."
Member of
Cataloging source
MMU
Dewey number
362.17/820973
Illustrations
illustrations
Index
no index present
Language note
English
LC call number
RA401.A3
LC item number
B74 2009eb
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
NLM call number
  • 2009 G-098
  • QV 736
NLM item number
W835b 2009
http://library.link/vocab/relatedWorkOrContributorName
  • Wizemann, Theresa M
  • Robinson, Sally
  • Giffin, Robert B
  • Institute of Medicine (U.S.)
http://library.link/vocab/subjectName
  • Orphan drugs
  • Pharmaceutical policy
  • Drugs
  • Orphan Drug Production
  • Orphan Drug Production
  • Models, Economic
  • Research
  • Research
  • United States
  • MEDICAL
  • Drugs
  • Orphan drugs
  • Pharmaceutical policy
  • United States
Label
Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies
Instantiates
Publication
Antecedent source
unknown
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
mixed
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Introduction and overview -- Current model for financing drug development: from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary
Control code
311565225
Dimensions
unknown
Extent
1 online resource (xviii, 132 pages)
File format
unknown
Form of item
online
Isbn
9786612083556
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Quality assurance targets
unknown
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
(OCoLC)311565225
Label
Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary, [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies
Publication
Antecedent source
unknown
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
mixed
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Introduction and overview -- Current model for financing drug development: from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary
Control code
311565225
Dimensions
unknown
Extent
1 online resource (xviii, 132 pages)
File format
unknown
Form of item
online
Isbn
9786612083556
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Quality assurance targets
unknown
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
(OCoLC)311565225

Library Locations

  • Curtis Laws Wilson LibraryBorrow it
    400 West 14th Street, Rolla, MO, 65409, US
    37.955220 -91.772210
  • Missouri University of Science & Technology Library DepositoryBorrow it
    2908 Lemone Blvd, Columbia, MO, 65201, US
    38.919360 -92.291620
Processing Feedback ...